Globus Medical Financial Statements (GMED)
|
|
|
|
Report date
|
|
|
17.02.2022 |
21.02.2023 |
21.02.2024 |
20.02.2025 |
24.02.2026 |
|
07.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
958.1 |
1 023 |
1 568 |
2 519 |
2 939 |
|
3 101 |
|
Operating Income, bln rub |
|
|
172.0 |
228.0 |
133.1 |
166.0 |
479.8 |
|
546.4 |
|
EBITDA, bln rub |
? |
|
264.7 |
304.5 |
346.6 |
473.7 |
729.9 |
|
886.4 |
|
Net profit, bln rub |
? |
|
149.2 |
190.2 |
122.9 |
103.0 |
537.9 |
|
586.7 |
|
|
OCF, bln rub |
? |
|
276.3 |
178.5 |
243.5 |
520.6 |
753.4 |
|
778.5 |
|
CAPEX, bln rub |
? |
|
56.9 |
74.0 |
78.3 |
115.4 |
164.7 |
|
173.2 |
|
FCF, bln rub |
? |
|
219.4 |
104.4 |
165.2 |
405.2 |
588.8 |
|
605.3 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
|
OPEX, bln rub |
|
|
546.9 |
531.2 |
887.2 |
1 318 |
1 501 |
|
1 559 |
|
Cost of production, bln rub |
|
|
239.2 |
263.7 |
548.2 |
1 035 |
957.8 |
|
996.5 |
|
R&D, bln rub |
|
|
97.3 |
73.0 |
124.0 |
163.8 |
185.0 |
|
188.4 |
|
Interest expenses, bln rub |
|
|
0.000 |
0.000 |
0.000 |
4.19 |
0.000 |
|
0.000 |
|
|
Assets, bln rub |
|
|
1 957 |
2 076 |
5 086 |
5 252 |
5 303 |
|
5 440 |
|
Net Assets, bln rub |
? |
|
1 741 |
1 846 |
3 998 |
4 177 |
4 573 |
|
4 732 |
|
Debt, bln rub |
|
|
0.000 |
6.01 |
520.4 |
537.2 |
118.7 |
|
115.2 |
|
Cash, bln rub |
|
|
443.4 |
446.1 |
517.8 |
890.1 |
557.2 |
|
629.9 |
|
Net debt, bln rub |
|
|
-443.4 |
-440.0 |
2.62 |
-352.9 |
-438.6 |
|
-514.6 |
|
|
Ordinary share price, rub |
|
|
72.2 |
74.3 |
53.3 |
82.7 |
87.3 |
|
86.2 |
|
Number of ordinary shares, mln |
|
|
100.7 |
100.5 |
113.1 |
135.7 |
135.2 |
|
135.4 |
|
|
Market cap, bln rub |
|
|
7 273 |
7 462 |
6 026 |
11 226 |
11 800 |
|
11 663 |
|
EV, bln rub |
? |
|
6 830 |
7 022 |
6 029 |
10 873 |
11 361 |
|
11 148 |
|
Book value, bln rub |
|
|
1 493 |
1 585 |
1 639 |
1 950 |
2 393 |
|
2 573 |
|
|
EPS, rub |
? |
|
1.48 |
1.89 |
1.09 |
0.76 |
3.98 |
|
4.33 |
|
FCF/share, rub |
|
|
2.18 |
1.04 |
1.46 |
2.99 |
4.36 |
|
4.47 |
|
BV/share, rub |
|
|
14.8 |
15.8 |
14.5 |
14.4 |
17.7 |
|
19.0 |
|
|
EBITDA margin, % |
? |
|
27.6% |
29.8% |
22.1% |
18.8% |
24.8% |
|
28.6% |
|
Net margin, % |
? |
|
15.6% |
18.6% |
7.83% |
4.09% |
18.3% |
|
18.9% |
|
FCF yield, % |
? |
|
3.02% |
1.40% |
2.74% |
3.61% |
4.99% |
|
5.19% |
|
ROE, % |
? |
|
8.57% |
10.3% |
3.07% |
2.47% |
11.8% |
|
12.4% |
|
ROA, % |
? |
|
7.62% |
9.16% |
2.42% |
1.96% |
10.1% |
|
10.8% |
|
|
P/E |
? |
|
48.7 |
39.2 |
49.0 |
109.0 |
21.9 |
|
19.9 |
|
P/FCF |
|
|
33.2 |
71.5 |
36.5 |
27.7 |
20.0 |
|
19.3 |
|
P/S |
? |
|
7.59 |
7.30 |
3.84 |
4.46 |
4.02 |
|
3.76 |
|
P/BV |
? |
|
4.87 |
4.71 |
3.68 |
5.76 |
4.93 |
|
4.53 |
|
EV/EBITDA |
? |
|
25.8 |
23.1 |
17.4 |
23.0 |
15.6 |
|
12.6 |
|
Debt/EBITDA |
|
|
-1.68 |
-1.45 |
0.01 |
-0.74 |
-0.60 |
|
-0.58 |
|
|
R&D/CAPEX, % |
|
|
171.1% |
98.6% |
158.4% |
141.9% |
112.3% |
|
108.8% |
|
|
CAPEX/Revenue, % |
|
|
5.94% |
7.24% |
4.99% |
4.58% |
5.60% |
|
5.59% |
|
| Globus Medical shareholders |
